Roch Doliveux - STRYKER Independent Director
| SYK Stock | EUR 367.70 0.00 0.00% |
Director
Dr. Roch Doliveux, DVM, is Independent Director of the Company, since June 21, 2010. He is a Chairman of the Board, Pierre Fabre SA, a global dermocosmetics and healthcare company. Chairman of GLG Institute, a community of senior executives for experience sharing and learning. Director of UCB, a global biopharmaceutical company, where he was Chief Executive Officer for 10 years. He is also Chairman of the Board of the Vlerick Business School, a top100 business school in the world based in Belgium and of the Caring Entrepreneurship Fund, a philanthropic organization to help entrepreneurs start their own businesses in healthcare since 2010.
| Age | 64 |
| Tenure | 14 years |
STRYKER Leadership Team
Elected by the shareholders, the STRYKER's board of directors comprises two types of representatives: STRYKER inside directors who are chosen from within the company, and outside directors, selected externally and held independent of STRYKER. The board's role is to monitor STRYKER's management team and ensure that shareholders' interests are well served. STRYKER's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, STRYKER's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Andrew Silvernail, Independent Director | ||
| Sherilyn McCoy, Independent Director | ||
| Ronda Stryker, Independent Director | ||
| Rajeev Suri, Independent Director | ||
| Preston Wells, Vice President - Investor Relations | ||
| Glenn Boehnlein, Chief Financial Officer, Vice President | ||
| Viju Menon, Group President - Global Quality and Business Operations | ||
| William Berry, Principal Accounting Officer, Vice President Corporate Controller | ||
| Allan Golston, Lead Independent Director | ||
| Mary Brainerd, Independent Director | ||
| Srikant Datar, Independent Director | ||
| Kevin Lobo, Chairman of the Board, Chief Executive Officer | ||
| Giovanni Caforio, Director | ||
| Roch Doliveux, Independent Director | ||
| Yin Becker, Vice President - Communications, Public Affairs and Corporate Marketing | ||
| M Fink, Chief Human Resource Officer, Vice President | ||
| Timothy Scannell, Group President - MedSurg and Neurotechnology | ||
| Robert Fletcher, Vice President Chief Legal Officer |
STRYKER Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is STRYKER a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Current Valuation | 101.82 B | |||
| Price To Book | 5.78 X | |||
| Price To Sales | 5.36 X | |||
| Revenue | 18.45 B | |||
| EBITDA | 4.04 B | |||
| Net Income | 2.36 B | |||
| Total Debt | 11.86 B | |||
| Cash Flow From Operations | 2.62 B | |||
| Price To Earnings To Growth | 2.83 X | |||
| Number Of Employees | 35 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Information and Resources on Investing in STRYKER Stock
When determining whether STRYKER is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if STRYKER Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Stryker Stock. Highlighted below are key reports to facilitate an investment decision about Stryker Stock:Check out World Market Map to better understand how to build diversified portfolios, which includes a position in STRYKER. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. For information on how to trade STRYKER Stock refer to our How to Trade STRYKER Stock guide.You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.